Trade Report: The FY2016 EPS Estimates for Stericycle Inc. Raised by Analyst (SRCL)

The FY2016 EPS Estimates for Stericycle Inc. Raised by Analyst (SRCL)

Stericycle Inc. (NASDAQ:SRCL) – Oppenheimer Holdings upped their FY2016 earnings per share (EPS) estimates for shares of Stericycle in a research note issued on Friday. Oppenheimer Holdings analyst S. Schneeberger now anticipates that the brokerage will earn $4.75 per share for the year, up from their prior estimate of $4.71. Oppenheimer Holdings also issued estimates for Stericycle’s Q4 2016 earnings at $1.22 EPS, Q1 2017 earnings at $1.14 EPS, Q2 2017 earnings at $1.16 EPS, Q3 2017 earnings at $1.16 EPS, Q4 2017 earnings at $1.21 EPS and FY2017 earnings at $4.67 EPS.

Several other analysts have also recently issued reports on the company. RBC Capital Markets reaffirmed an “underperform” rating and set a $77.00 target price (down previously from $89.00) on shares of Stericycle in a research report on Monday, September 19th. Macquarie initiated coverage on Stericycle in a research report on Thursday, August 25th. They issued a “neutral” rating and a $96.00 price objective for the company. Jefferies Group set a $108.00 price objective on Stericycle and gave the stock a “buy” rating in a research report on Tuesday, October 25th. Zacks Investment Research cut Stericycle from a “hold” rating to a “strong sell” rating in a research report on Friday, October 7th. Finally, Stifel Nicolaus raised Stericycle from a “hold” rating to a “buy” rating and set a $90.00 price objective for the company in a research report on Friday. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $98.58.

Shares of Stericycle (NASDAQ:SRCL) opened at 79.73 on Monday. The firm has a 50-day moving average price of $77.86 and a 200-day moving average price of $94.04. Stericycle has a 12 month low of $72.89 and a 12 month high of $128.94. The stock has a market cap of $6.82 billion, a PE ratio of 28.98 and a beta of 0.20.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Thursday, October 27th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.07. The company earned $890.10 million during the quarter, compared to analysts’ expectations of $899.87 million. Stericycle had a return on equity of 15.41% and a net margin of 7.52%. Stericycle’s revenue for the quarter was up 23.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.08 earnings per share.

Several institutional investors have recently made changes to their positions in the stock. Capstone Asset Management Co. raised its position in shares of Stericycle by 0.3% in the third quarter. Capstone Asset Management Co. now owns 7,633 shares of the company’s stock valued at $612,000 after buying an additional 20 shares in the last quarter. Parkside Financial Bank & Trust raised its position in shares of Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock valued at $149,000 after buying an additional 41 shares in the last quarter. Genesee Valley Trust Co. raised its position in shares of Stericycle by 1.0% in the second quarter. Genesee Valley Trust Co. now owns 4,511 shares of the company’s stock valued at $470,000 after buying an additional 43 shares in the last quarter. Spero Smith Investment Advisers Inc. OH raised its position in shares of Stericycle by 0.3% in the second quarter. Spero Smith Investment Advisers Inc. OH now owns 16,883 shares of the company’s stock valued at $1,758,000 after buying an additional 50 shares in the last quarter. Finally, Ameritas Investment Partners Inc. raised its position in shares of Stericycle by 1.7% in the second quarter. Ameritas Investment Partners Inc. now owns 3,091 shares of the company’s stock valued at $322,000 after buying an additional 53 shares in the last quarter. Hedge funds and other institutional investors own 92.76% of the company’s stock.

In related news, Director Rodney F. Dammeyer sold 10,188 shares of Stericycle stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total value of $871,074.00. Following the completion of the transaction, the director now owns 10,188 shares in the company, valued at approximately $871,074. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP John P. Schetz sold 1,398 shares of Stericycle stock in a transaction dated Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total value of $114,426.30. Following the completion of the transaction, the executive vice president now owns 1,088 shares of the company’s stock, valued at approximately $89,052.80. The disclosure for this sale can be found here. Company insiders own 3.30% of the company’s stock.

Stericycle Company Profile

Related posts

Leave a Comment